Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Galluzzi, L.
Right arrow Articles by Karp, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galluzzi, L.
Right arrow Articles by Karp, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Amplified Detection of Transcriptional and Translational Inhibitors in Bioluminescent Escherichia Coli K-12

Lorenzo Galluzzi

University of Turku, Department of Biotechnology, Turku, Finland., Università degli studi di Modena e Reggio Emilia, Modena, Italy.

Matti Karp

University of Turku, Department of Biotechnology, Turku, Finland. matti.karp{at}utu.fi

The excessive prescription of antimicrobial agents and their use as animal growth promoters lead to the spread of resistance among pathogenic bacteria. Consequently, unnecessary use should be minimized, and new chemicals with novel mechanisms of action are needed. The authors have developed a fast method to measure the activity of antibiotics by means of a genetically engineered strain of Escherichia coli K-12. The system is based on the full-length bacterial luciferase operon coupled to the tetracycline-inducible tetA promoter in the reporter plasmid pTetLux1. Sublethal doses of tetracycline are used to start the luciferase synthesis in cultures that were previously incubated with the antibiotic under investigation. After a variable time frame—from 1 to 4 h, depending on the antimicrobial mode of action—the level of light emission from treated cultures is compared to the level obtained in control cultures. The gap in bioluminescence outlines the antibiotic interference in bacterial metabolism. Throughout this study, freeze-dried sensor cells were used to avoid repeated cultures from day to day. The authors show the results of 10 model antibiotics, representing different molecular structures and mechanisms of action. The results show that no actively dividing cells are needed for sensitive responses, especially when transcriptional and translational inhibitors, directly interfering with the luciferase production, are tested. The assay can be easily automated for high-throughput screening purposes of pharmaceutical industry. (Journal of Biomolecular Screening 2003:340-346)

Key Words: Escherichia coli • antibiotics • bioluminescence • high-throughput screening • inducible reporter system

Journal of Biomolecular Screening, Vol. 8, No. 3, 340-346 (2003)
DOI: 10.1177/1087057103008003012


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
S. H. Cho, S. Warit, B. Wan, C. H. Hwang, G. F. Pauli, and S. G. Franzblau
Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium tuberculosis
Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1380 - 1385.
[Abstract] [Full Text] [PDF]